Eckert & Ziegler Future Growth
Future criteria checks 1/6
Eckert & Ziegler is forecast to grow earnings and revenue by 7.6% and 6.4% per annum respectively. EPS is expected to grow by 8.6% per annum. Return on equity is forecast to be 16.8% in 3 years.
Key information
7.6%
Earnings growth rate
8.57%
EPS growth rate
| Medical Equipment earnings growth | 13.3% |
| Revenue growth rate | 6.4% |
| Future return on equity | 16.80% |
| Analyst coverage | Low |
| Last updated | 09 Jun 2026 |
Recent future growth updates
Recent updates
Analysis Article • Mar 30
Earnings Miss: Eckert & Ziegler SE Missed EPS By 29% And Analysts Are Revising Their Forecasts
Eckert & Ziegler SE ( ETR:EUZ ) last week reported its latest annual results, which makes it a good time for investors...Analysis Article • Jan 10
Why Eckert & Ziegler SE (ETR:EUZ) Could Be Worth Watching
While Eckert & Ziegler SE ( ETR:EUZ ) might not have the largest market cap around , it saw a decent share price growth...Analysis Article • Sep 29
What Eckert & Ziegler SE's (ETR:EUZ) P/E Is Not Telling You
When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 18x, you may consider...
Narrative Update • Sep 19
Expanding Radioisotope Production Will Fuel Global Personalized Medicine
The upward revision in Eckert & Ziegler’s price target reflects modest improvements in both future P/E and net profit margin, resulting in a new consensus fair value of €22.85. What's in the News Confirmed 2025 earnings guidance with expected sales of approximately €320 million and EBIT before special items of about €78 million.Analysis Article • Sep 13
Do Eckert & Ziegler's (ETR:EUZ) Earnings Warrant Your Attention?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Narrative Update • Sep 04
Expanding Radioisotope Production Will Fuel Global Personalized Medicine
With no material changes in either the discount rate or future P/E ratio, analysts left Eckert & Ziegler’s fair value estimate effectively unchanged at €21.67. What's in the News Eckert & Ziegler confirmed 2025 guidance, expecting sales of around €320 million and EBIT before special items of around €78 million.Analysis Article • Jun 12
The Compensation For Eckert & Ziegler SE's (ETR:EUZ) CEO Looks Deserved And Here's Why
Key Insights Eckert & Ziegler to hold its Annual General Meeting on 18th of June Salary of €360.0k is part of CEO...Analysis Article • May 20
Eckert & Ziegler's (ETR:EUZ) Solid Earnings Have Been Accounted For Conservatively
Investors signalled that they were pleased with Eckert & Ziegler SE's ( ETR:EUZ ) most recent earnings report...Analysis Article • May 08
Eckert & Ziegler SE's (ETR:EUZ) P/E Is Still On The Mark Following 27% Share Price Bounce
Eckert & Ziegler SE ( ETR:EUZ ) shareholders are no doubt pleased to see that the share price has bounced 27% in the...Analysis Article • Apr 19
What Is Eckert & Ziegler SE's (ETR:EUZ) Share Price Doing?
Eckert & Ziegler SE ( ETR:EUZ ), is not the largest company out there, but it saw a decent share price growth of 16% on...Analysis Article • Mar 17
Eckert & Ziegler (ETR:EUZ) Has A Pretty Healthy Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Feb 28
If EPS Growth Is Important To You, Eckert & Ziegler (ETR:EUZ) Presents An Opportunity
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
New Narrative • Feb 10
European GalliaPharm Approval And Telix Partnership Will Open New Markets And Strengthen Future Prospects
European market expansion via GalliaPharm approval and strategic partnerships drive new revenue streams and improved earnings potential.Analysis Article • Aug 08
Eckert & Ziegler SE's (ETR:EUZ) Share Price Could Signal Some Risk
With a price-to-earnings (or "P/E") ratio of 25x Eckert & Ziegler SE ( ETR:EUZ ) may be sending bearish signals at the...Analysis Article • Jul 17
Does Eckert & Ziegler (ETR:EUZ) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysis Article • Jun 20
Why We Think Eckert & Ziegler SE's (ETR:EUZ) CEO Compensation Is Not Excessive At All
Key Insights Eckert & Ziegler's Annual General Meeting to take place on 26th of June Total pay for CEO Harald...Analysis Article • Jun 05
Investors Met With Slowing Returns on Capital At Eckert & Ziegler (ETR:EUZ)
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...Analysis Article • May 13
Is Now An Opportune Moment To Examine Eckert & Ziegler SE (ETR:EUZ)?
Eckert & Ziegler SE ( ETR:EUZ ), is not the largest company out there, but it led the XTRA gainers with a relatively...Analysis Article • Apr 27
Eckert & Ziegler SE (ETR:EUZ) Investors Are Less Pessimistic Than Expected
With a price-to-earnings (or "P/E") ratio of 25.5x Eckert & Ziegler SE ( ETR:EUZ ) may be sending very bearish signals...Analysis Article • Apr 12
Here's Why Eckert & Ziegler (ETR:EUZ) Can Manage Its Debt Responsibly
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysis Article • Mar 06
Slowing Rates Of Return At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Leave Little Room For Excitement
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...Analysis Article • Jan 04
What Eckert & Ziegler Strahlen- und Medizintechnik AG's (ETR:EUZ) P/E Is Not Telling You
With a price-to-earnings (or "P/E") ratio of 29.5x Eckert & Ziegler Strahlen- und Medizintechnik AG ( ETR:EUZ ) may be...Analysis Article • Dec 20
Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Has A Pretty Healthy Balance Sheet
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analysis Article • Nov 15
Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Hasn't Managed To Accelerate Its Returns
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...Analysis Article • Oct 01
What Is Eckert & Ziegler Strahlen- und Medizintechnik AG's (ETR:EUZ) Share Price Doing?
Eckert & Ziegler Strahlen- und Medizintechnik AG ( ETR:EUZ ), might not be a large cap stock, but it saw a decent share...Analysis Article • Aug 22
A Look At The Intrinsic Value Of Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)
Key Insights Eckert & Ziegler Strahlen- und Medizintechnik's estimated fair value is €36.79 based on 2 Stage Free Cash...Analysis Article • Jul 16
These 4 Measures Indicate That Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Analysis Article • Jun 22
Is It Time To Consider Buying Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?
Eckert & Ziegler Strahlen- und Medizintechnik AG ( ETR:EUZ ), is not the largest company out there, but it saw...Analysis Article • May 17
The Return Trends At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Look Promising
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Analysis Article • Mar 20
Is Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ) Potentially Undervalued?
Eckert & Ziegler Strahlen- und Medizintechnik AG ( ETR:EUZ ), is not the largest company out there, but it received a...Analysis Article • Jan 24
Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Returns Have Hit A Wall
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Analysis Article • Oct 27
We Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Can Stay On Top Of Its Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2028 | 375 | 61 | 60 | 86 | 3 |
| 12/31/2027 | 344 | 55 | 39 | 71 | 3 |
| 12/31/2026 | 322 | 52 | 39 | 67 | 3 |
| 3/31/2026 | 317 | 49 | 30 | 57 | N/A |
| 12/31/2025 | 312 | 49 | 32 | 58 | N/A |
| 9/30/2025 | 304 | 41 | 44 | 66 | N/A |
| 6/30/2025 | 299 | 41 | 57 | 75 | N/A |
| 3/31/2025 | 296 | 41 | 52 | 70 | N/A |
| 12/31/2024 | 296 | 40 | 49 | 67 | N/A |
| 9/30/2024 | 278 | 36 | 31 | 53 | N/A |
| 6/30/2024 | 274 | 38 | 11 | 36 | N/A |
| 3/31/2024 | 256 | 34 | 11 | 38 | N/A |
| 12/31/2023 | 246 | 30 | 11 | 38 | N/A |
| 9/30/2023 | 240 | 33 | 18 | 43 | N/A |
| 6/30/2023 | 233 | 29 | 21 | 44 | N/A |
| 3/31/2023 | 230 | 30 | 10 | 35 | N/A |
| 12/31/2022 | 222 | 31 | 7 | 34 | N/A |
| 9/30/2022 | 215 | 27 | -9 | 29 | N/A |
| 6/30/2022 | 198 | 27 | -8 | 32 | N/A |
| 3/31/2022 | 186 | 27 | 5 | 39 | N/A |
| 12/31/2021 | 180 | 35 | 5 | 34 | N/A |
| 9/30/2021 | 180 | 33 | 26 | 38 | N/A |
| 6/30/2021 | 182 | 31 | 35 | 41 | N/A |
| 3/31/2021 | 176 | 30 | 22 | 28 | N/A |
| 12/31/2020 | 176 | 21 | 28 | 35 | N/A |
| 9/30/2020 | 172 | 21 | 21 | 28 | N/A |
| 6/30/2020 | 173 | 22 | 19 | 26 | N/A |
| 3/31/2020 | 179 | 21 | 30 | 37 | N/A |
| 12/31/2019 | 178 | 22 | N/A | 40 | N/A |
| 9/30/2019 | 178 | 22 | N/A | 37 | N/A |
| 6/30/2019 | 177 | 21 | N/A | 31 | N/A |
| 3/31/2019 | 177 | 20 | N/A | 28 | N/A |
| 12/31/2018 | 169 | 16 | N/A | 21 | N/A |
| 9/30/2018 | 162 | 16 | N/A | 20 | N/A |
| 6/30/2018 | 155 | 14 | N/A | 21 | N/A |
| 3/31/2018 | 142 | 11 | N/A | 23 | N/A |
| 12/31/2017 | 139 | 12 | N/A | 27 | N/A |
| 9/30/2017 | 131 | 11 | N/A | 31 | N/A |
| 6/30/2017 | 124 | 11 | N/A | 30 | N/A |
| 3/31/2017 | 117 | 11 | N/A | 24 | N/A |
| 12/31/2016 | 120 | 10 | N/A | 20 | N/A |
| 9/30/2016 | 127 | 9 | N/A | 14 | N/A |
| 6/30/2016 | 132 | 9 | N/A | 13 | N/A |
| 3/31/2016 | 142 | 11 | N/A | 16 | N/A |
| 12/31/2015 | 140 | 12 | N/A | 16 | N/A |
| 9/30/2015 | 137 | 11 | N/A | 17 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EUZ's forecast earnings growth (7.6% per year) is above the savings rate (1.9%).
Earnings vs Market: EUZ's earnings (7.6% per year) are forecast to grow slower than the German market (16.7% per year).
High Growth Earnings: EUZ's earnings are forecast to grow, but not significantly.
Revenue vs Market: EUZ's revenue (6.4% per year) is forecast to grow slower than the German market (6.6% per year).
High Growth Revenue: EUZ's revenue (6.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EUZ's Return on Equity is forecast to be low in 3 years time (16.8%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/30 17:43 |
| End of Day Share Price | 2026/06/30 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Eckert & Ziegler SE is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Thielmann | Berenberg |
| Christian Ehmann | Berenberg |
| Adrian Kowollik | Dr. Kalliwoda Research |